National Health Commission of the People’s Republic of China [to 5 Jun 2021]
June 5: Daily briefing on novel coronavirus cases in China
On June 4, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 24 new cases of confirmed infections.
China’s Sinopharm COVID-19 vaccine to COVAX in production
BEIJING — China on June 1 said the first batch of Chinese vaccines supplied to COVAX officially rolled off the production line, which is another important reflection of China’s commitment to making its COVID-19 vaccines global public goods with concrete actions…
China reports adverse reaction rate of 11.86 out of 100,000 COVID-19 vaccine doses
BEIJING — The incidence of adverse reactions to COVID-19 vaccines in China is 11.86 out of 100,000 doses, the Chinese Center for Disease Control and Prevention (China CDC) said on May 28…
National Medical Products Administration – PRC [to 5 Jun 2021]
Over 700 mln COVID-19 vaccine doses administered across China
More than 704.8 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission (NHC) said on June 3.